← Leaderboards
Scot A Wolfe
Boston Children'S Hospital
$14,652,054
Attributed
$31,862,857
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,862,857 · 12
By mechanism
R01$18,447,952 · 6
U01$6,580,415 · 1
UH3$3,091,036 · 1
UG3$2,473,416 · 1
R21$780,788 · 2
S10$489,250 · 1
Top collaborators
- Erik J Sontheimer12 shared
- Nathan D Lawson10 shared
- Jonathan K Watts7 shared
- Anastasia Khvorova6 shared
- Jeremy Luban5 shared
- Daniel Evan Bauer4 shared
- Michael H Brodsky3 shared
- Charles P Emerson2 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Daniel Evan Bauer$19,160,492
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesSpecificityNucleaseTechnologyGenomicsBaseGenomeEngineeringRepairedProteinsSiteAnimal ModelMutationAllelesGene TargetingMediatingIn VivoGenome EditingReagentAreaCellsGenerationsGene TherapyModification
Grant awards (48)
Precision Editing of Granulin Mutations that Cause Frontotemporal Dementia$6,580,415
U01 · FY2025 · NS
Rectifying splicing mutations in blood disorders by gene editing$855,537
R01 · FY2023 · HL
Enhancing CRISPR Gene Editing in Somatic Tissues by Chemical Modification of Guides and Donors$1,370,507
UH3 · FY2022 · TR
Rectifying splicing mutations in blood disorders by gene editing$861,736
R01 · FY2022 · HL
Enhancing CRISPR Gene Editing in Somatic Tissues by Chemical Modification of Guides and Donors$333,834
UH3 · FY2022 · TR
Enhancing CRISPR Gene Editing in Somatic Tissues by Chemical Modification of Guides and Donors$1,386,695
UH3 · FY2021 · TR
Rectifying splicing mutations in blood disorders by gene editing$866,772
R01 · FY2021 · HL
Rectifying splicing mutations in blood disorders by gene editing$890,593
R01 · FY2020 · HL
Enhancing CRISPR Gene Editing in Somatic Tissues by Chemical Modification of Guides and Donors$819,031
UG3 · FY2020 · TR
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus$937,745
R01 · FY2019 · AI
Enhancing CRISPR Gene Editing in Somatic Tissues by Chemical Modification of Guides and Donors$828,360
UG3 · FY2019 · TR
Engineered Cas9 Nucleases with Single-Genomic-Site Precision for CYBB Correction$398,059
R01 · FY2019 · GM · contact PI
A comprehensive gene repair therapy for FKRP neuromuscular diseases$209,375
R21 · FY2019 · NS
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus$937,745
R01 · FY2018 · AI
Enhancing CRISPR Gene Editing in Somatic Tissues by Chemical Modification of Guides and Donors$826,025
UG3 · FY2018 · TR
Engineered Cas9 Nucleases with Single-Genomic-Site Precision for CYBB Correction$398,059
R01 · FY2018 · GM · contact PI
A comprehensive gene repair therapy for FKRP neuromuscular diseases$251,250
R21 · FY2018 · NS
Engineered Cas9 Nucleases with Single-Genomic-Site Precision for CYBB Correction$50,020
R01 · FY2018 · GM · contact PI
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus$914,295
R01 · FY2017 · AI
Using site-specific nucleases to manipulate the zebrafish genome$418,750
R01 · FY2017 · HL · contact PI
Engineered Cas9 Nucleases with Single-Genomic-Site Precision for CYBB Correction$388,765
R01 · FY2017 · GM · contact PI
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus$914,295
R01 · FY2016 · AI
Using site-specific nucleases to manipulate the zebrafish genome$418,750
R01 · FY2016 · HL · contact PI
Engineered Cas9 Nucleases with Single-Genomic-Site Precision for CYBB Correction$401,355
R01 · FY2016 · GM · contact PI
Next generation hybrid nucleases for precise excision of latent HIV-1 provirus$931,045
R01 · FY2015 · AI
Using site-specific nucleases to manipulate the zebrafish genome$412,468
R01 · FY2015 · HL · contact PI
Using site-specific nucleases to manipulate the zebrafish genome$410,375
R01 · FY2014 · HL · contact PI
Using site-specific nucleases to manipulate the zebrafish genome$396,270
R01 · FY2013 · HL · contact PI
Dimeric Cys2His2 Zinc Finger Proteins for Gene Targeting$314,310
R01 · FY2013 · GM · contact PI
Using zinc finger nucleases to manipulate genome$406,065
R01 · FY2012 · HL
Dimeric Cys2His2 Zinc Finger Proteins for Gene Targeting$325,710
R01 · FY2012 · GM · contact PI
Using zinc finger nucleases to manipulate the zebrafish genome$410,195
R01 · FY2011 · HL
Dimeric Cys2His2 Zinc Finger Proteins for Gene Targeting$325,710
R01 · FY2011 · GM · contact PI
Systematic Analysis of Drosophila transcription factor binding specificities$620,417
R01 · FY2010 · HG · contact PI
Illumina Genome Analyzer IIx for UMass Deep Sequencing Core$489,250
S10 · FY2010 · RR · contact PI
Using zinc finger nucleases to manipulate the zebrafish genome$422,253
R01 · FY2010 · HL
Dimeric Cys2His2 Zinc Finger Proteins for Gene Targeting$328,417
R01 · FY2010 · GM · contact PI
Systematic Analysis of Drosophila transcription factor binding specificities$609,035
R01 · FY2009 · HG · contact PI
Using zinc finger nucleases to manipulate the zebrafish genome$415,564
R01 · FY2009 · HL
Systematic Analysis of Drosophila transcription factor binding specificities$643,280
R01 · FY2008 · HG · contact PI
Using zinc finger nucleases to manipulate the zebrafish genome$414,237
R01 · FY2008 · HL
Dimeric Cys2His2 Zinc Finger Proteins for Gene Targeting$278,153
R01 · FY2008 · GM · contact PI
Dimeric Cys2His2 Zinc Finger Proteins for Gene Targeting$278,153
R01 · FY2007 · GM · contact PI
A bacterial one-hybrid system for analyzing DNA-binding specificities$157,788
R21 · FY2007 · HG · contact PI
Dimeric Cys2His2 Zinc Finger Proteins for Gene Targeting$286,461
R01 · FY2006 · GM · contact PI
A bacterial one-hybrid system for analyzing DNA-binding specificities$162,375
R21 · FY2006 · HG · contact PI
Dimeric Cys2His2 Zinc Finger Proteins for Gene Targeting$293,355
R01 · FY2005 · GM
Dimeric Cys2His2 Zinc Finger Proteins for Gene Targeting$274,003
R01 · FY2004 · GM